We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
7 hedge funds and large institutions have $3.02M invested in Windtree Therapeutics in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less ownership
Funds ownership: 0% → 0% (-0%)
23% less capital invested
Capital invested by funds: $3.94M → $3.02M (-$925K)
50% less funds holding
Funds holding: 14 → 7 (-7)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
Holders
7
Holders Change
-7
Holders Change %
-50%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
–
Closed
7
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$1K
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$170K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$85.1K |
| 3 |
Renaissance Technologies
New York
|
+$85.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$85.1K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$255K |
| 2 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$156K |
| 3 |
Goldman Sachs
New York
|
-$153K |
| 4 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
-$137K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$88K |
